LILRB1 and amblyopia: A proof-of-concept experiment that demonstrated the benefit of acute PIRB blockade on synaptic function was application of soluble extracellular domain of PIRB (sPIRB) into visual cortex of adult mice affected by amblyopia (cortical blindness) [79].